Hepatotoxicity in patients prescribed efavirenz or nevirapine.

Sandra Brück, S. Witte, Jürgen Brust, D. Schuster, Franz Mosthaf, Maria Procaccianti, J. A. Rump, Hartwig Klinker, D. Petzold, M. Hartmann

PubMed · 2008 · 60 citations · 0 references

Abstract

Increases of liver enzymes during therapy with NVP or EFV are not unusual, but are mostly mild-to-moderate and asymptomatic. LEE occurs just as frequent in patients prescribed EFV as in patients prescribed NVP.